(Q53762262)

English

Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progression.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: cessation of CTL responses is associated with disease progression. (English)

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

1 reference

based on heuristic

inferred from title

author name string

M H Andersen

1

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

P Keikavoussi

2

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

E B Bröcker

3

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

B Schuler-Thurner

4

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

M Jonassen

5

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

I Søndergaard

6

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

P T Straten

7

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

J C Becker

8

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

E Kämpgen

9

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

International Journal of Cancer

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

94

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

6

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

820-824

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

Human tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

In situ T cells in melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Dendritic cells as adjuvants for immune-mediated resistance to tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Rapid effector function in CD8+ memory T cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Signal transduction by lymphocyte antigen receptors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Prognostic factors for survival of patients treated systemically for disseminated melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Cancer vaccines

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cell clonotypes that are lost during in vitro culture

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

A sensitive ELISPOT assay to detect low-frequency human T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Where have all the T cells gone? Mechanisms of immune evasion by tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1536

21 January 2018

Identifiers

10.1002/IJC.1536

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

1 reference

Europe PubMed Central

19 May 2018

http://europepmc.org/abstract/MED/11745484

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53762262&oldid=2046658003"